<unk>  is a selective norepinephrine reuptake inhibitor that is FDA approved for the treatment of attention-deficit/hyperactivity disorder(ADHD). There is a Black Box Warning for this drug as shown here.  Common adverse reactions include nausea, vomiting, fatigue, decreased appetite, abdominal pain, and somnolence.
Atomoxetine
Guanfacine
Dapoxetine
Vortioxetine
Duloxetine
Norfluoxetine
Fluoxetine
Nabilone